MARKET

AVDL

AVDL

Avadel Pharmaceu
NASDAQ
21.54
-0.01
-0.05%
After Hours: 21.49 -0.05 -0.22% 17:00 12/30 EST
OPEN
21.54
PREV CLOSE
21.55
HIGH
21.60
LOW
21.52
VOLUME
553.41K
TURNOVER
--
52 WEEK HIGH
23.57
52 WEEK LOW
6.38
MARKET CAP
2.11B
P/E (TTM)
-3916.3636
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AVDL last week (1222-1226)?
Weekly Report · 1d ago
Regencell Bioscience is the top performing pharma stock YTD
Seeking Alpha · 12/23 04:47
Weekly Report: what happened at AVDL last week (1215-1219)?
Weekly Report · 12/22 09:45
Wells Fargo Keeps Their Hold Rating on Avadel Pharmaceuticals (AVDL)
TipRanks · 12/18 16:15
Analysts Have Conflicting Sentiments on These Healthcare Companies: Avadel Pharmaceuticals (AVDL) and Novan (NOVN)
TipRanks · 12/18 14:50
Avadel Completes Enrollment in Phase 3 LUMRYZ Trial
TipRanks · 12/18 12:28
Avadel Pharmaceuticals Completes Enrollment in Phase 3 Trial of LUMRYZ for Idiopathic Hypersomnia
Reuters · 12/18 12:01
AVADEL PHARMACEUTICALS PLC - DATA EXPECTED IN Q2 2026
Reuters · 12/18 12:00
More
About AVDL
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's product, LUMRYZ, is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the challenges patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA. Its MICROPUMP technology allows for the development of modified-release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified-release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.

Webull offers Avadel Pharmaceuticals PLC (ADR) stock information, including NASDAQ: AVDL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVDL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVDL stock methods without spending real money on the virtual paper trading platform.